.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Fish and Richardson
US Army
Baxter
Farmers Insurance
Boehringer Ingelheim
Express Scripts
Novartis
US Department of Justice
Harvard Business School

Generated: September 24, 2017

DrugPatentWatch Database Preview

Methohexital sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methohexital sodium and what is the scope of methohexital sodium freedom to operate?

Methohexital sodium
is the generic ingredient in one branded drug marketed by Par Sterile Products and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for methohexital sodium. One supplier is listed for this compound.

Summary for Generic Name: methohexital sodium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list25
Clinical Trials: see list2,392
Patent Applications: see list2,554
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methohexital sodium at DailyMed

Pharmacology for Ingredient: methohexital sodium

Ingredient-typeBarbiturates
Drug ClassBarbiturate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-004Dec 21, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Argus Health
UBS
US Department of Justice
AstraZeneca
Dow
Colorcon
Citi
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot